<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01365715</url>
  </required_header>
  <id_info>
    <org_study_id>H-2-2011-024</org_study_id>
    <secondary_id>H-2-2011-024</secondary_id>
    <secondary_id>2008-41-2128</secondary_id>
    <nct_id>NCT01365715</nct_id>
  </id_info>
  <brief_title>Preoperative Embolization in Surgical Treatment of Spinal Metastases.</brief_title>
  <official_title>Preoperative Embolization in Surgical Treatment of Spinal Metastases. A Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main purpose of this study is to assess the efficacy of preoperative embolization in
      decreasing operative blood loss, decreasing the need for intraoperative transfusion and
      facilitate surgical resection in metastatic spine surgery. Furthermore the study aims at
      describing the vascularity in a series of spinal metastasis, and to correlate this with
      perioperative blood loss.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Actual">February 2014</completion_date>
  <primary_completion_date type="Actual">February 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Perioperative blood loss</measure>
    <time_frame>Measured intraoperatively and 24 hours postoperatively.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Perioperative blood transfusion volume</measure>
    <time_frame>Intraoperatively and until 48 hours postoperatively.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical procedure time.</measure>
    <time_frame>At skin closure.</time_frame>
    <description>Defined as the amount of time (measured in minutes) from skin incision to skin closure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vascularization grade of metastasis</measure>
    <time_frame>At the angiographic procedure prior to embolization performed 0-48 hours before surgery.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Success of embolization</measure>
    <time_frame>Directly after the embolization performed 0-48 hours before surgery.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events related to angiography or embolization</measure>
    <time_frame>Within 2 postoperative days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events related to surgery</measure>
    <time_frame>Within 2 postoperative days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">48</enrollment>
  <condition>Spinal Metastases</condition>
  <arm_group>
    <arm_group_label>Preoperative embolization</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>32 patients with spinal metastasis/metastases will undergo arteriography and receive transcatheter arterial embolization of spinal metastasis/metastases 0-48 hours prior to surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>32 patients with spinal metastasis/metastases will undergo arteriography of spinal metastasis/metastases without receiving transcatheter arterial embolization prior to surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Arteriography and preoperative embolization</intervention_name>
    <description>Arteriography and transcatheter arterial embolization of spinal metastasis/metastases 0-48 hours prior to surgery.</description>
    <arm_group_label>Preoperative embolization</arm_group_label>
    <other_name>Transcatheter arterial embolization</other_name>
    <other_name>Selective arterial embolization</other_name>
    <other_name>Therapeutic angiography</other_name>
    <other_name>Embolization</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Arteriography</intervention_name>
    <description>Arteriography of spinal metastasis/metastases without transcatheter arterial embolization prior to surgery.</description>
    <arm_group_label>Control group</arm_group_label>
    <other_name>Angiography</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients scheduled for decompression and posterior thoracic and/or lumbar instrumented
             spinal fusion because of spinal metastasis/metastases.

          -  Informed signed consent.

        Exclusion Criteria:

          -  Contrast fluid allergy.

          -  Clotting disorders.

          -  Renal failure.

          -  Not suitable for arterial access.

          -  Pregnancy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lars LÃ¶nn, MD, Ph.d.</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Radiology, Rigshospitalet. Copenhagen, Denmark.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Radiology, Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <link>
    <url>http://www.rigshospitalet.dk</url>
  </link>
  <verification_date>February 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 27, 2011</study_first_submitted>
  <study_first_submitted_qc>June 1, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 3, 2011</study_first_posted>
  <last_update_submitted>February 25, 2014</last_update_submitted>
  <last_update_submitted_qc>February 25, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 26, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Caroline Clausen</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Preoperative embolization</keyword>
  <keyword>Transcatheter arterial embolization</keyword>
  <keyword>Therapeutic angiography</keyword>
  <keyword>Embolization</keyword>
  <keyword>Surgical blood loss</keyword>
  <keyword>Spinal metastases</keyword>
  <keyword>Spinal neoplasms</keyword>
  <keyword>Vertebral metastases</keyword>
  <keyword>metastatic spine surgery</keyword>
  <keyword>Spinal surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasm Metastasis</mesh_term>
    <mesh_term>Neoplasms, Second Primary</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

